Poxel SA - Special Call Transcript
Ladies and gentlemen, welcome to the Poxel Conference Call. I now hand call over to Jonae Barnes. Madam, please go ahead.
Thank you for joining us today. With me on the call are Thomas Kuhn , CEO; Christophe Arbet-Engels, Chief Medical Officer and EVP Late Development and Medical Affairs; Pascale Fouqueray, EVP of Early Development and Translational Medicine; and Renevot, our Chief Financial Officer; and Noah Beerman, President of U.S. Operations and Executive Vice President of Business Development. Before we begin, I would like to read our forward-looking statement. Some of the statements contained in this presentation constitute forward-looking statements, which are statements that are not historical facts. These statements are based on the company's current strategy, plans, objectives, assumptions, estimates and projections. Investors should, therefore, not place undue reliance on these statements.
The company makes no representation, warranty or prediction that the results anticipated by
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
